PATHWAY PROFILING ANTIBODIES & REAGENTS

     
Products
Product : Recombinant Protein >> Epidermal Growth Factor (EGF) recombinant protein (human)
Back  >   Printable Version  >  Download in PDF  > 
Recombinant human Epidermal Growth Factor (EGF)
 
Cat. No.DescriptionFormatUnitPrice(USD)QuantityBulk Quotation
IMR-292-0100
Epidermal Growth Factor (EGF) recombinant protein (human)Protein
100 µg
--
     
Catalog No
: IMR-292-0100

Description
Epidermal growth factor (EGF) is a neurotrophic factor that promotes the survival of various neuronal cell types and may play an important role in the injury response in the nervous system. Recombinant human Epidermal Growth Factor produced in E. coli is a single, non-glycosylated polypeptide chain containing 53 amino acids and having a molecular mass of 6,222 Daltons.
Physical Appearance
Sterile Filtered; white lyophilized (freeze-dried) powder.
Formulation
100 ug of lyophilized protein
Stability
Lyophilized product is very stable at -20°C. Reconstituted material should be aliquoted and frozen at -20°C. It is recommended to add a carrier protein (0.1% HSA or BSA) for long term storage.
Purity
Purity greater than 95% as determined by: Analysis by RP-HPLC, reducing and non-reducing SDS-PAGE.
Amino Acid Sequence
NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR
Biological Activity
Recombinant human Epidermal Growth Factor is fully biologically active when compared to standards. The ED50, calculated by the dose-dependent proliferation of murine BALB/c 3T3 cells, is 20.25 pg/ml.
Endotoxin
Endotoxin level as measured by LAL is <0.01ng/ug or <0.1EU/ug.
Protein Content
Protein content determined by: UV spectroscopy at 280 nm. Analysis by RP-HPLC calibrated against a known standard. Quantitation on SDS-PAGE against a known standard.
   

 

 


Research purposes only. Not for diagnostic or in vivo use.

Products

Services

Resources

Purchasing

Company

  • What's New
  • Reporter Cell Lines
  • Screening Services
  • Interactive Pathways